Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in Arthritis

Buprenorphine is recommended for use as an analgesic in animal models including in murine models of collagen-induced arthritis (CIA). However, the effect of buprenorphine on the expression of disease-associated biomarkers is not well defined. We examined the effect of buprenorphine administration on...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahadevappa Hemshekhar, Vidyanand Anaparti, Carol Hitchon, Neeloffer Mookherjee
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2017/2515408
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849409415253327872
author Mahadevappa Hemshekhar
Vidyanand Anaparti
Carol Hitchon
Neeloffer Mookherjee
author_facet Mahadevappa Hemshekhar
Vidyanand Anaparti
Carol Hitchon
Neeloffer Mookherjee
author_sort Mahadevappa Hemshekhar
collection DOAJ
description Buprenorphine is recommended for use as an analgesic in animal models including in murine models of collagen-induced arthritis (CIA). However, the effect of buprenorphine on the expression of disease-associated biomarkers is not well defined. We examined the effect of buprenorphine administration on disease progression and the expression of inflammatory and oxidative stress markers, in a murine model of CIA. Buprenorphine administration altered the expression of cytokines, IFN-γ, IL-6, and MMP-3, and oxidative markers, for example, iNOS, superoxide dismutase (SOD1), and catalase (CAT), in the CIA mice. As buprenorphine is an analgesic, we further monitored the association of expression of these biomarkers with pain scores in a human cohort of early rheumatoid arthritis (RA). Serum MMP-3 levels and blood mRNA expression of antioxidants sod1 and cat correlated with pain scores in the RA cohort. We have demonstrated that administration of buprenorphine alters the expression of inflammatory and oxidative stress-related molecular markers in a murine model of CIA. This caveat needs to be considered in animal experiments using buprenorphine as an analgesic, as it can be a confounding factor in murine studies used for prediction of response to therapy. Furthermore, the antioxidant enzymes that showed an association with pain scores in the human cohort may be explored as biomarkers for pain in future studies.
format Article
id doaj-art-7ccc0960fddd4693b8668cc314bb89af
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-7ccc0960fddd4693b8668cc314bb89af2025-08-20T03:35:29ZengWileyMediators of Inflammation0962-93511466-18612017-01-01201710.1155/2017/25154082515408Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in ArthritisMahadevappa Hemshekhar0Vidyanand Anaparti1Carol Hitchon2Neeloffer Mookherjee3Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, MB, CanadaManitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, MB, CanadaDepartment of Internal Medicine, University of Manitoba, Winnipeg, MB, CanadaManitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, MB, CanadaBuprenorphine is recommended for use as an analgesic in animal models including in murine models of collagen-induced arthritis (CIA). However, the effect of buprenorphine on the expression of disease-associated biomarkers is not well defined. We examined the effect of buprenorphine administration on disease progression and the expression of inflammatory and oxidative stress markers, in a murine model of CIA. Buprenorphine administration altered the expression of cytokines, IFN-γ, IL-6, and MMP-3, and oxidative markers, for example, iNOS, superoxide dismutase (SOD1), and catalase (CAT), in the CIA mice. As buprenorphine is an analgesic, we further monitored the association of expression of these biomarkers with pain scores in a human cohort of early rheumatoid arthritis (RA). Serum MMP-3 levels and blood mRNA expression of antioxidants sod1 and cat correlated with pain scores in the RA cohort. We have demonstrated that administration of buprenorphine alters the expression of inflammatory and oxidative stress-related molecular markers in a murine model of CIA. This caveat needs to be considered in animal experiments using buprenorphine as an analgesic, as it can be a confounding factor in murine studies used for prediction of response to therapy. Furthermore, the antioxidant enzymes that showed an association with pain scores in the human cohort may be explored as biomarkers for pain in future studies.http://dx.doi.org/10.1155/2017/2515408
spellingShingle Mahadevappa Hemshekhar
Vidyanand Anaparti
Carol Hitchon
Neeloffer Mookherjee
Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in Arthritis
Mediators of Inflammation
title Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in Arthritis
title_full Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in Arthritis
title_fullStr Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in Arthritis
title_full_unstemmed Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in Arthritis
title_short Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in Arthritis
title_sort buprenorphine alters inflammatory and oxidative stress molecular markers in arthritis
url http://dx.doi.org/10.1155/2017/2515408
work_keys_str_mv AT mahadevappahemshekhar buprenorphinealtersinflammatoryandoxidativestressmolecularmarkersinarthritis
AT vidyanandanaparti buprenorphinealtersinflammatoryandoxidativestressmolecularmarkersinarthritis
AT carolhitchon buprenorphinealtersinflammatoryandoxidativestressmolecularmarkersinarthritis
AT neeloffermookherjee buprenorphinealtersinflammatoryandoxidativestressmolecularmarkersinarthritis